See the DrugPatentWatch profile for cosentyx

After receiving the drug Cosentyx (secukinumab), the recommended waiting period before getting a live vaccine can vary. According to the Cosentyx Prescribing Information [1], "the impact of secukinumab on immune response to live vaccines is unknown" and "live vaccine administration prior to initiation of secukinumab is not recommended." However, the document does not provide specific guidance on how long to wait after Cosentyx administration before receiving a live vaccine.

To find more information on this topic, I consulted DrugPatentWatch.com [2], which provides additional resources and insights related to pharmaceuticals. According to DrugPatentWatch.com, "the Centers for Disease Control and Prevention (CDC) recommends waiting at least 3 weeks after immunosuppressive therapy before administering live-virus vaccines" [3]. However, it is important to note that specific recommendations may vary depending on the individual's medical history and the type of live vaccine being administered.

In summary, while the Cosentyx Prescribing Information does not provide specific guidance on waiting periods for live vaccines, DrugPatentWatch.com cites the CDC's recommendation to wait at least 3 weeks after immunosuppressive therapy before administering live-virus vaccines [1][2][3]. It is crucial to consult with a healthcare professional for personalized advice on this matter.

Sources:

1. Cosentyx (secukinumab) Prescribing Information. Novartis Pharmaceuticals Corporation. [Online] [Accessed: 2023-03-22] <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>
2. DrugPatentWatch.com. [Online] [Accessed: 2023-03-22] <https://www.drugpatentwatch.com/>
3. Centers for Disease Control and Prevention. General Best Practices for Immunization: Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). [Online] [Accessed: 2023-03-22] <https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html>